11 unknown, 10 completed, 3 recruiting, 2 not yet recruiting. 13 Not applicable, 7 Phase 4, 4 Phase 2, 2 Phase 1, 1 Early Phase 1.
Follow Basic treatment: new trials by email Literature Review of Basic treatment trials Research Report on Basic treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis Nalfurafine Hydrochloride, Basic treatment - Chronic Kidney Disease-Associated Pruritus in Hemodialysis | Not applicable | Not yet recruiting | Chinese PLA General Hospital | 150 | 2026-07-01 | 2026-06-16 |
| YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2 the traditional Chinese medicine prescription ' Shenzhuo Decoction ', basic treatment - Diabetic Kidney Disease (DKD) | Not applicable | Not yet recruiting | Liu Hongfang | 228 | 2025-08-01 | 2025-06-24 |
| Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa Deep transcranial magnetic stimulation, cognitive behavior therapy, Sham deep transcranial magnetic stimulation - Feeding and Eating Disorders | Not applicable | Recruiting | Shanghai Mental Health Center | 110 | 2025-04-30 | 2025-05-11 |
| Effect of Oral Feeding on Patients With Chronic Obstructive Pulmonary Disease Basic treatment, Oral Tube Feeding, Nasogastric Tube Feeding - Chronic Obstructive Pulmonary Disease | Not applicable | Unknown | Chao Phya Abhaibhubejhr Hospital | 80 | 2024-07-01 | 2024-07-17 |
| A New Neuroregulatory Technology for the Therapy of AN Based on the Pathological Neural Network of ACC Deep transcranial magnetic stimulation, Sham deep transcranial magnetic stimulation, Basic treatment - Feeding and Eating Disorders | Not applicable | Unknown | Shanghai Mental Health Center | 80 | 2024-04-30 | 2024-04-26 |
| The Impact of Different Feeding Modes on Patients With Intracerebral Hemorrhage Basic treatment, Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding - Intracerebral Hemorrhage | Not applicable | Unknown | Copka Sonpashan | 120 | 2024-03-01 | 2024-03-25 |
| Effect of Different Feeding Modes in Intracerebral Hemorrhage Intermittent Oro-esophageal Tube Feeding, Basic treatment, Nasogastric Tube Feeding - Intracerebral Hemorrhage | Not applicable | Completed | Zeng Changhao | 118 | 2024-02-28 | 2025-12-22 |
| Efficacy and Safety of Fire Needle Therapy Combined With Cortex Phellodendri Compound Fluid Wet Compress for Acute Herpes Zoster: a Randomized Controlled Trial. Fire needle, Cortex Phellodendri compound fluid wet compress, basic treatment - Acute Herpes Zoster | Phase 4 | Completed | Second Affiliated Hospital of Xi'an Jiaotong University | 32 | 2024-01-01 | 2025-05-22 |
| RY_SW01 Cell Injection Therapy in Systemic Sclerosis RY_SW01 cell injection, Basic treatment - Systemic Sclerosis | Phase 1 / Phase 2 | Recruiting | Jiangsu Renocell Biotech Company | 81 | 2023-09-22 | 2024-01-18 |
| RY_SW01 Cell Injection Therapy in Active Lupus Nephritis RY_SW01 cell injection, Basic treatment - Lupus Nephritis | Phase 2 | Recruiting | Jiangsu Renocell Biotech Company | 60 | 2023-08-17 | 2024-01-18 |
| Accelerated Recovery for Total Knee Replacement Surgery With Preoperative Intravenous Iron Combined With Human Erythropoietin for Rapid Hematopoietic Mobilization to Prevent Postoperative Anemia Ferric Derisomaltose Injection (Monoferric) and Human Erythropoietin Injection (EPIAO), Basic Treatment - Total Knee Arthroplasty | Not applicable | Unknown | West China Hospital | 419 | 2023-07-01 | 2023-06-22 |
| The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque Qushi Formula, Zhu's Wenban Formula, placebo - Protein; Disease, Carotid Artery Plaque | Phase 1 | Unknown | Guangzhou University of Traditional Chinese Medicine | 300 | 2023-05-31 | 2023-03-14 |
| Effect of Intermittent Oro-esophageal Tube vs Nasogastric Tube in Tracheostomized Patients With Intracerebral Hemorrhage Basic treatment, comprehensive rehabilitation therapy, Intermittent Oro-esophageal Tube Feeding - Intracerebral Hemorrhage | Not applicable | Terminated | Zeng Changhao | 118 | 2023-01-17 | 2024-03-08 |
| The Efficacy and Safety of Azovudine in the Treatment of COVID-19 Azorubine - COVID-19, Infections | Unknown | Fuzhou General Hospital | 500 | 2023-01-04 | 2023-01-10 | |
| Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder Basic treatment, PSA, TSA - Major Depressive Disorder | Not applicable | Completed | The Third Affiliated hospital of Zhejiang Chinese Medical University | 160 | 2022-11-01 | 2025-08-22 |
| Hydrogen-Oxygen Generator With Nebulizer for Rehabilitation Treatment of COVID-19 Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, basic treatment - COVID-19, AMS-H-03 | Not applicable | Unknown | Shanghai Zhongshan Hospital | 216 | 2022-08-12 | 2022-08-17 |
| Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease Live Combined Bifidobacterium and Lactobacillus, Normal saline, Basic treatment - Functional Constipation, Irritable Bowel Syndrome | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 160 | 2022-07-04 | 2022-08-04 |
| Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment Huatuo Zaizao Pills, Basic treatment - Ischemic Stroke | Phase 4 | Completed | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 80 | 2021-05-31 | 2024-11-29 |
| Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of COVID-19 The drug "Rutan 0.1"., Basic treatment - Patients With COVID-19 | Phase 2 | Completed | Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan | 57 | 2020-10-12 | 2023-05-16 |
| Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Jinshuibao, Placebo - Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4 | Phase 4 | Unknown | Jemincare | 332 | 2020-04-30 | 2020-04-20 |
Showing 20 of 27. Sign in to see all of them.
COVID-19 (4) · Cerebral Hemorrhage (3) · Angina, Stable (2) · Anorexia Nervosa (2) · Feeding and Eating Disorders (2) · Ischemic Stroke (2) · Angina Pectoris (1) · Carotid Stenosis (1) · Depressive Disorder, Major (1) · Diabetic Nephropathies (1) · Disease (1) · Glomerulonephritis (1) · Infections (1) · Irritable Bowel Syndrome (1) · Lupus Nephritis (1)
Chengdu University of Traditional Chinese Medicine (2) · Jiangsu Renocell Biotech Company (2) · Shanghai Mental Health Center (2) · Zeng Changhao (2) · Beijing Continent Pharmaceutical Co, Ltd. (1) · Beijing YouAn Hospital (1) · Chao Phya Abhaibhubejhr Hospital (1) · Chinese PLA General Hospital (1) · Copka Sonpashan (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Fuzhou General Hospital (1) · Guangzhou University of Traditional Chinese Medicine (1) · Harvard University (1) · Jemincare (1) · Jieming QU (1)
China (21) · Ghana (1) · Uzbekistan (1)
Jue Chen, PHD (2) · Nieto Luis, Master (2) · Erkin Musabaev, Professor (1) · Fanrong Liang (1) · Gunther Fink, PhD (1) · HongFang Liu (1) · Jing Wang (1) · Nieto Luis (1) · Ronghua Jin (1) · Slawa Rokicki, MS, BS (1) · Sun Lingyun (1) · Weihui Zeng (1) · Xiaogang Li (1) · Xiaomei Shao, Ph.D (1) · Yun Feng, M.D. (1)
PMID 24499445, PMID 24843959, PMID 25250055, PMID 29262823, PMID 30232851, PMID 31355870, PMID 33763912, PMID 34387828, PMID 35215786, PMID 35830201, PMID 37441145, PMID 37802518, PMID 38924142, PMID 40232598, PMID 41207313